Condition
ICH
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04320108Not ApplicableCompleted
ESWT for Shoulder Pain in Patients With Brain Damage
NCT05611918Enrolling By Invitation
REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study
NCT01489137Not ApplicableCompleted
The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation
NCT01556620Completed
Is NIRS Able to Detect Ischemia Following Brain Insult
Showing all 4 trials